The 2018 Annual Conference will take place at the Mercure Bristol Grand Hotel, Thursday 29 – Friday 30 November and celebrates 10 years since the creation of this group.
Download the main programme here
Three major international speakers will join us from Canada and the United States.
Dr David Palma from London, Ontario and Dr Drew Moghanaki, Virginia, United States and Dr Sean P. Collins from Georgetown University, United States.
Topics to be covered include:
- Complexities and solutions for randomised trials of surgery versus SABR for stage I NSCLC
- SABR for unfavorable prostate cancer: An emerging standard of care?
- New evidence in treating oligometastases; from COMET to CORE and beyond
Book your place today and join us in Bristol.
2018 Principal sponsor
Accuray develops, manufactures and sells radiotherapy systems that make cancer treatments shorter, safer, personalized and more effective.
Our radiation treatment delivery systems – the CyberKnife® and the Radixact® Systems – in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures.
We work passionately to create a future without the fear, pain or human suffering of cancer. We pursue this by developing precise, innovative tumor treatment solutions that empower clinicians and help cancer patients live longer, better lives.
Visit us at www.accuray.com
2018 Gold sponsors
Varian of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer.
The company is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian employs approximately 6,500 people at sites around the world.
For more information, visit www.varian.com and follow @VarianMedSys on Twitter.
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders.
Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows.
Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com.
2017 Annual conference
The 2017 conference which was held at Glasgow Central Hotel from 30 November – 01 December was a huge success with over 200 attendees.
An excellent line up of speakers helped bring together like-minded professionals for an outstanding 2 days of education and networking.
View the full programme here.